Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 10, 2012, Pages 1389-1398

  Serafini, G ^a   Pompili, M ^a,b   Innamorati, M ^a   Gentile, G ^a   Borro, M ^a   Lala, N ^c   Negro, A ^c,d   Simmaco, M ^a   Girardi, P ^a   Martelletti, P ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MCLEAN HOSPITAL   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Affective temperaments; Chronic migraine; Gene variants; Hopelessness; Suicidal behaviour

Indexed keywords

ADULT; AFFECTIVE TEMPERAMENTAL DYSREGULATION; AGED; ARTICLE; CYP1A2 1F GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GNB3 GENE; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MAO A3 GENE; PERSONALITY DISORDER; RISK FACTOR; SUICIDAL BEHAVIOR; TRANSFORMED MIGRAINE; CHRONIC DISEASE; EMOTIONAL DISORDER; GENETICS; MIDDLE AGED; MIGRAINE; RISK; SUICIDE; TEMPERAMENT;

AMINE OXIDASE (FLAVIN CONTAINING); CYP1A2 PROTEIN, HUMAN; CYTOCHROME P450 1A2; G PROTEIN BETA3 SUBUNIT; G-PROTEIN BETA3 SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AFFECTIVE SYMPTOMS; AGED; CHRONIC DISEASE; CYTOCHROME P-450 CYP1A2; FEMALE; GENETIC VARIATION; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; MONOAMINE OXIDASE; RISK; SUICIDE; TEMPERAMENT;

EID: 84871880303     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. WHO. Figures and facts about suicide (No. HO/MNH/MBD/99.1). Geneva, Author, 1999.
2. WHO. Suicide prevention in Europe. Geneva, Author, 2002.
3. POMPILI M, DI COSIMO D, INNAMORATI M, LESTER D, TATARELLI R, MARTELLETTI P. Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain 2009; 10: 283-290.
4. POMPILI M, SERAFINI G, DI COSIMO D, DOMINICI G, INNAMORATI M, LESTER D, FORTE A, GIRARDI N, DE FILIPPIS S, TATARELLI R, MARTELLETTI P. Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat 2010; 6: 81-91.
5. MCGUFFIN P, MARUSIC A, FARMER A. What can psychiatric genetics offer suicidology? Crisis 2001; 22: 61-65.
6. VORACEK MM, LOIBL LM. Genetics of suicide: a systematic review of twin studies. Wien Klin Wochenschr 2007; 119: 463-475. (Pubitemid 47382919)
7. ROY A. Genetic and biologic risk factors for suicide in depressive disorders. Psychiatr Q 1993; 64: 345-358.
8. SHIMADA T, YAMAZAKI H, M. MIMURA M, INUI Y, GUNGERICH FP. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Expe Ther 1994; 270: 414-423. (Pubitemid 24229655)
9. NAKAJIMA M, YOKOI T, MIZUTANI M, KINOSHITA M, FUNAYAMA M, KAMAKATI T. Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem 1999; 125: 803-808. (Pubitemid 29192503)
10. SACHSE C, BROCKMOLLER J, BAUER S, ROOTS I. Functional significance of a C>A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine. British J Clin Pharmacol 1999; 47: 445-449. (Pubitemid 29161279)
11. HUI P, NAKAYAMA T, MORITA A, SATO N, HISHIKI M, SAITO K, YOSHIKAWA Y, TAMURA M, SATO I, TAKAHASHI T, SOMA M, IZUMI Y, OZAWA Y, CHENG Z. Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption. Hypertens Res 2007; 30: 585-592. (Pubitemid 47278315)
12. HUANG X, JU Z, SONG Y, ZHANG H, SUN K, LU H, YANG Z, JOSE PA, ZHOU G, WANG M, WANG W, FENG S, HUI R. Lack of association between the G protein beta3 subunit gene and essential hypertension in Chinese: a case-control and a familybased study. J Mol Med 2003; 81: 729-735. (Pubitemid 37491599)
13. POCH E, GINER V, GONZÁLEZ-NÚÑEZ D, COLL E, ORIOLA J, DE LA SIERRA A. Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin Exp Hypertens 2002; 24: 345-353 (Pubitemid 34743398)
14. BENJAFIELD AV, LIN RC, DALZIEL B, GOSBY AK, CATERSON ID, MORRIS BJ. G-protein beta3 subunit gene splice variant in obesity and overweight International. Int J Obes Relat Metab Disord 2001; 25: 777-780. (Pubitemid 32601368)
15. MANZONI GC, BONAVITA V, BUSSONE G, CORTELLI P, NARBONE MC, CEVOLI S, D'AMICO D, DE SIMONE R, TORELLI P. Chronic migraine classification: current knowledge and future perspectives. J Headache Pain 2011; 12: 585-592.
16. DECKERT J, CATALANO M, SYAGAILO YV, BOSI M, OKLADNOVA O, DI BELLA D, NÖTHEN MM, MAFFEI P, FRANKE P, FRITZE J, MAIER W, PROPPING P, BECKMANN H, BELLODI L, LESCH KP. Excess ofhigh activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999; 8: 621-624. (Pubitemid 29139976)
17. BECK AT, WEISSMAN A, LESTER D, TREXLER L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42: 861-865.
18. AKISKAL HS, AKISKAL KK. TEMPS: Temperament Evaluation of Memphis, Pisa, Paris and San Diego. J Affect Disord 2005; 85: 1-2. (Pubitemid 40386520)
19. INNAMORATI M, POMPILI M, SERAFINI G, LESTER D, ERBUTO D, AMORE M, TATARELLI R, GIRARDI P. Psychometric properties of the Suicidal History Self-Rating Screening. Arch Suicide Res 2011; 15: 1-6.
20. BECK AT, BROWN G, BERCHICK RJ, STEWART BL, STEER RA. Relationship between hopelessness and ultimate suicide: A replication with psychiatric outpatients. Am J Psychiatry 1990; 147: 190-195. (Pubitemid 20060472)
21. POMPILI M, INNAMORATI M, LESTER D, AKISKAL HS, RIHMER Z, DEL CASALE A, AMORE M, GIRARDI P, TATARELLI R. Substance abuse, temperament and suicide risk: Evidence from a case control study. J Addict Dis 2009; 28: 13-20.
22. POMPILI M, TATARELLI R, ROGERS JR, LESTER D. The Hopelessness Scale: A factor analysis. Psychol Rep 2007; 100: 375-378.
23. SERAFINI G, POMPILI M, INNAMORATI M, FUSAR-POLI P, AKISKAL HS, RIHMER Z, LESTER D, ROMANO A, DE OLIVEIRA IR, STRUSI L, FERRACUTI S, GIRARDI P, TATARELLI R. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders. J Affect Disord 2011; 129: 47-55.
24. GIRARDI P, POMPILI M, INNAMORATI M, SERAFINI G, BERRETTONI C, ANGELETTI G, KOUKOPOULOS A, TATARELLI R, LESTER D, ROSELLI D, PRIMIERO FM. Temperament, post-partum depression, hopelessness, and suicide risk among women soon after delivering. Women Health 2011; 51: 511-524.
25. POMPILI M, INNAMORATI M, RIHMER Z, GONDA X, SERAFINI G, AKISKAL H, AMORE M, NIOLU C, SHER L, TATARELLI R, PERUGI G, GIRARDI P. Cyclothymic- depressiveanxious temperament pattern is related to suicide risk in 346 patients with major mood disorders. J Affect Disord 2012; 136: 405-411.
26. POMPILI M, RIHMER Z, AKISKAL H, AMORE M, GONDA X, INNAMORATI M, LESTER D, PERUGI G, SERAFINI G, TELESFORO L, TATARELLI R, GIRARDI P. Temperaments mediate suicide risk and psychopathology among patients with bipolar disorders. Compr Psychiatry 2012; 53: 280-285.
27. DE LUCA V, THARMALINGAM S, SICARD T, KENNEDY JL. Gene-gene interaction between MAOA and COMT in suicidal behaviour. Neurosci Lett 2005; 383: 151-154. (Pubitemid 40779973)
28. De Luca V, Tharmaligam S, Strauss J, Kennedy JL. 5-HT2C receptor and MAO-A interaction analysis: no association with suicidal behaviour in bipolar patients. Eur Arch Psychiatry Clin Neurosci 2008; 258: 428-433.
29. KUNUGI H, ISHIDA S, KATO T, TATSUMI M, SAKAI T, HATTORI M, HIROSE T, NANKO S. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 1999; 4: 393-395. (Pubitemid 29440582)
30. DE LUCA V, THARMALINGAM S, MÜLLER DJ, WONG G, DE BARTOLOMEIS A, KENNEDY JL. Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia. Brain Res 2006; 1097: 26-30. (Pubitemid 44063490)
31. GERRA G, GAROFANO L, BOSARI S, PELLEGRINI C, ZAIMOVIC A, MOI G, BUSSANDRI M, MOI A, BRAMBILLA F, MAMELI A, PIZZAMIGLIO M, DONNINI C. Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates. J Neural Transm 2004; 111: 611-621. (Pubitemid 38530067)
32. COURTET P, JOLLANT F, BURESI C, CASTELNAU D, MOUTHON D, MALAFOSSE A. The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr Genet 2005; 15: 189-193. (Pubitemid 41231941)
33. ONO H, SHIRAKAWA O, NISHIGUCHI N, NISHIMURA A, NUSHIDA H, UENO Y, MAEDA K. No evidence of an association between a functional monoamine oxidase a gene polymorphism and completed suicides. Am J Med Genet 2002; 114: 340-342. (Pubitemid 34258863)
34. SABOL SZ, HU S, HAMER D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103: 273-279. (Pubitemid 28470076)
35. GENTILE G, BORRO M, LALA N, MISSORI S, SIMMACO M, MARTELLETTI P. Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain 2010; 11: 431-435.
36. GENTILE G, MISSORI S, BORRO M, SEBASTIANELLI A, SIMMACO M, MARTELLETTI P. Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain 2010; 11: 151-156.
37. MANUCK SB, FLORY JD, FERRELL RE, MANN JJ, MULDOON MF. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity Psychiatry Res 2000; 95: 9-23. (Pubitemid 30445200)
38. JOLLANT F, BURESI C, GUILLAUME S, JAUSSENT I, BELLIVIER F, LEBOYER M, CASTELNAU D, MALAFOSSE A, COURTET P. The influence of four serotoninrelated genes on decision-making in suicide attempters Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 615-624. (Pubitemid 47077145)
39. DU L, FALUDI G, PALKOVITS M, SOTONYI P, BAKISH D, HRDINA PD. High activityrelated allele of MAO-A gene associated with depressed suicide in males. Neuroreport 2002; 13: 1195-1198. (Pubitemid 34722052)
40. FURLONG RA, KERAMATIPOUR M, HO LW, RUBINSZTEIN JS, MICHAEL A, WALSH C, PAYKEL ES, RUBINSZTEIN DC. No association of an insertion/deletion polymorphism in the angiotensin I converting enzyme gene with bipolar or unipolar affective disorders. Am J Med Genet 2000; 96: 733-735.
41. HUANG YY, CATE SP, BATTISTUZZI C, OQUENDO MA, BRENT D, MANN JJ. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 2004; 29: 1498-1505. (Pubitemid 38982242)
42. HO LW, FURLONG RA, RUBINSZTEIN JS, WALSH C, PAYKEL ES, RUBINSZTEIN DC. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 2000; 96: 36-42. (Pubitemid 30077647)
43. LUNG FW, TZENG DS, HUANG MF, LEE MB. Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder BMC Med Genet 2011; 12: 74.
44. LIN KM, TSOU HH, TSAI IJ, HSIAO MC, HSIAO CF, LIU CY, SHEN WW, TANG HS, FANG CK, WU CS, LU SC, KUO HW, LIU SC, CHAN HW, HSU YT, TIAN JN, LIU YL. CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine. Pharmacogenomics 2010; 11: 1535-1543.
45. LAIKA B, LEUCHT S, HERES S, SCHNEIDER H, STEIMER W. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. Pharmacogenomics J 2010; 10: 20-29.
46. SERRETTI A, CALATI R, MASSAT I, LINOTTE S, KASPER S, LECRUBIER Y, SENS-ESPEL R, BOLLEN J, ZOHAR J, BERLO J, LIENARD P, DE RONCHI D, MENDLEWICZ J, SOUERY D. Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. Int Clin Psychopharmacol 2009; 24: 250-256.
47. KLENKE S, KUSSMANN M, SIFFERT W. The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics 2011; 21: 594-606.
48. LEE HJ, CHA JH, HAM BJ, HAN CS, KIM YK, LEE SH, RYU SH, KANG RH, CHOI MJ, LEE MS. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J 2004; 4: 29-33.
49. NEGRO A, MARTELLETTI P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 2011; 12: 593-601.
50. BRENT DA, MELHEM N. Familial transmission of suicidal behaviour. Psychiatr Clin North Am 2008; 31: 157-177.
51. TURECKI G. Dissecting the suicide phenotype: the role of impulsive aggressive behaviours. J Psychiatry Neurosci 2005; 30: 398-408. (Pubitemid 41812486)
52. BRODSKY BS, OQUENDO M, ELLIS SP, HAAS GL, MALONE KM, MANN JJ. The relationship of childhood abuse to impulsivity and suicidal behaviour in adults with major depression. Am J Psychiatry 2001; 158: 1871-1877. (Pubitemid 33054781)